Korean J Gastroenterol.  2016 Nov;68(5):288-290. 10.4166/kjg.2016.68.5.288.

The Influence of Proton Pump Inhibitor Use on the Gut Microbiome

Affiliations
  • 1Department of Internal Medicine, Hanyang University Guri Hospital, Hanyang University College of Medicine, Guri, Korea.
  • 2Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea. sklee@yuhs.ac

Abstract

No abstract available.


MeSH Terms

Gastrointestinal Microbiome*
Proton Pumps*
Protons*
Proton Pumps
Protons

Reference

References

1. Moayyedi P, Talley NJ. Gastro-oesophageal reflux disease. Lancet. 2006; 367:2086–2100.
Article
2. Othman F, Card TR, Crooks CJ. Proton pump inhibitor prescribing patterns in the UK: a primary care database study. Pharmacoepidemiol Drug Saf. 2016; 25:1079–1087.
Article
3. Tleyjeh IM, Bin Abdulhak AA, Riaz M, et al. Association between proton pump inhibitor therapy and clostridium difficile infection: a contemporary systematic review and metaanalysis. PLoS One. 2012; 7:e50836.
Article
4. Masclee GM, Coloma PM, Kuipers EJ, Sturkenboom MC. Increased risk of microscopic colitis with use of proton pump inhibitors and non-steroidal anti-inflammatory drugs. Am J Gastroenterol. 2015; 110:749–759.
Article
5. Lambert AA, Lam JO, Paik JJ, Ugarte-Gil C, Drummond MB, Crowell TA. Risk of community-acquired pneumonia with outpatient proton-pump inhibitor therapy: a systematic review and metaanalysis. PLoS One. 2015; 10:e0128004.
Article
6. Imhann F, Bonder MJ, Vich Vila A, et al. Proton pump inhibitors affect the gut microbiome. Gut. 2016; 65:740–748.
Article
7. Faleck DM, Salmasian H, Furuya EY, Larson EL, Abrams JA, Freedberg DE. Proton pump inhibitors do not increase risk for clostridium difficile infection in the intensive care unit. Am J Gastroenterol. 2016. DOI: doi:10.1038/ajg.2016.343. [Epub ahead of print].
Article
8. Washio E, Esaki M, Maehata Y, et al. Proton pump inhibitors increase incidence of nonsteroidal anti-inflammatory drug-induced small bowel injury: a randomized, placebo-controlled trial. Clin Gastroenterol Hepatol. 2016; 14:809–815.e1.
9. Blackler RW, Gemici B, Manko A, Wallace JL. NSAID-gastro- enteropathy: new aspects of pathogenesis and prevention. Curr Opin Pharmacol. 2014; 19:11–16.
10. Wallace JL, Syer S, Denou E, et al. Proton pump inhibitors exacerbate NSAID-induced small intestinal injury by inducing dysbiosis. Gastroenterology. 2011; 141:1314–1322. 1322.e1–5.
Article
11. McDonald EG, Milligan J, Frenette C, Lee TC. Continuous proton pump inhibitor therapy and the associated risk of recurrent Clostridium difficile infection. JAMA Intern Med. 2015; 175:784–791.
Full Text Links
  • KJG
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr